Sravan Kumar Emany is CFO & VP at IRONWOOD PHARMACEUTICALS INC (IRWD). They have made 4 open-market trades across 1 company since 2022, most recently 2026-05-05.
CIK 0001897662
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $801K since 2023, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BEAM | SELL · 10b5-1 | 2025-12-31 | 2026-01-05 | $27.10 | $171K | +19.6% | +0.6% | -9.6% |
| IRWD | SELL | 2024-11-18 | 2024-11-20 | $4.08 | $45K | +0.3% | +26.1% | -43.3% |
| IRWD | BUY | 2024-03-04 | 2024-03-06 | $9.38 | $200K | -3.8% | -8.9% | -26.3% |
| IRWD | BUY | 2023-09-15 | 2023-09-18 | $8.32 | $600K | +7.1% | +7.7% | +24.9% |
| IRWD | SELL | 2022-11-21 | 2022-11-23 | $11.56 | $152K | +3.2% | +7.3% | +0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.